Shanghai Universal Biotech Co.,Ltd.

301166

CNE100005709

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 15/07/2024 am IST			5-day change	1st Jan Change
26.2 ^CNY	-1.21%		-2.86%	-31.81%

02/07	Tranche Update on Shanghai Universal Biotech Co.,Ltd.'s Equity Buyback Plan announced on March 2, 2024.	CI
26/04	Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Tranche Update on Shanghai Universal Biotech Co.,Ltd.'s Equity Buyback Plan announced on March 2, 2024.

July 03, 2024 at 01:11 am IST

From April 1, 2024 to June 30, 2024, the company has repurchased 180,500 shares, representing 0.21% for CNY 5.29 million. With this, the company has completed the repurchase of 213,700 shares, representing 0.25% for CNY 6.28 million under the buyback announced on March 2, 2024.

Latest news about Shanghai Universal Biotech Co.,Ltd.

Tranche Update on Shanghai Universal Biotech Co.,Ltd.'s Equity Buyback Plan announced on March 2, 2024.	03/07	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	22/04	CI
Tranche Update on Shanghai Universal Biotech Co.,Ltd.'s Equity Buyback Plan announced on March 2, 2024.	01/04	CI
Shanghai Universal Biotech Co.,Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	01/03	CI
Shanghai Universal Biotech Co.,Ltd. authorizes a Buyback Plan.	29/02	CI
Sengenics Corporation LLC Enters into Sales Distribution and Services Agreement with Shanghai Universal Biotech Co., Ltd	27/02	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	26/23/26	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/22/26	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/22/29	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	25/22/25	CI
Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	24/22/24	CI
Absin Bioscience Inc. announced that it expects to receive CNY 71 million in funding from Shanghai Universal Biotech Co.,Ltd.	20/22/20	CI
Shanghai LabEx Biotechnology Co., Ltd. announced that it expects to receive CNY 15 million in funding from Shanghai Universal Biotech Co.,Ltd.	20/22/20	CI

Chart Shanghai Universal Biotech Co.,Ltd.

Duration

Period

Chart Shanghai Universal Biotech Co.,Ltd.

More charts

Company Profile

Shanghai Universal Biotech Co Ltd is a China-based company mainly engaged in the supply of life science reagent products. The Company is also engaged in the supply of life science instruments and consumables and comprehensive technical services. The products supplied by the Company are mainly third-party brand products, supplemented by independent brand products. The life science reagents mainly include immunological reagents based on antibodies and antibody related reagents, as well as molecular biology reagents, cell biology reagents and biochemical reagents. The life science instruments and consumables include detection and analysis and sample preparation. The comprehensive technical services include experimental services, technical support services and other services.

Sector

Pharmaceuticals

Calendar

30/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
SHANGHAI UNIVERSAL BIOTECH CO.,LTD.	-31.81%	32Cr
MCKESSON CORPORATION	+24.90%	7.48TCr
CARDINAL HEALTH, INC.	-7.00%	2.29TCr
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+14.82%	873.72Cr
SINOPHARM GROUP CO. LTD.	-4.16%	793.85Cr
HUADONG MEDICINE CO., LTD	-33.26%	669.22Cr
H. LUNDBECK A/S	+20.70%	566.07Cr
EBOS GROUP LIMITED	-3.10%	402.13Cr
MEDIPAL HOLDINGS CORPORATION	+12.40%	341.31Cr
CHINA NATIONAL MEDICINES CORPORATION LTD.	+7.79%	318.48Cr